Patent · US Active

Humanized antibodies against PSMA

US11976131B2 · kind B2 · utility

0Cited by

0References

20Claims

0Family size

Assignee

Heidelberg Pharma Research GmbH · DE

Inventors

Torsten Hechler · Ladenburg, DE
Andreas Pahl · Ladenburg, DE

Key dates

Filing date	Jul 30, 2019
Grant date	May 7, 2024
Priority date	—
Expiry date	Feb 9, 2041

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2317/92
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present application relates to humanized and/or deimmunized antibodies, antibody fragments or antibody derivatives that bind to Prostate Specific Membrane Antigen (PSMA) and methods for using said antibodies, antibody fragments or antibody derivatives in the treatment of prostate cancer and other neoplastic as well as neurological diseases.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.